Health Blueprint

Back to Longevity News

News summary

Routine Invasive Procedures for Stable Heart Disease Offer No Long-Term Survival Advantage Over Drug Therapy

Source: PR Newswire • Published: 07 Nov 2026, 16:07

Summarized by Masters of Longevity from PR Newswire.

Nearly decade-long follow-up found similar death rates between strategies.

Routine Invasive Procedures for Stable Heart Disease Offer No Long-Term Survival Advantage Over Drug Therapy
Key Takeaways
  • Early procedures were not found to extend survival.
  • Conservative medical therapy was found to yield similar mortality.
  • These results are limited to stable chronic coronary disease.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickSeed Oils and Health: Inflammation, Processing and EvidenceHuman trials, processing risks and long-term health ask different questions. What can seed-oil research tell us—and what remains unresolved?MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.